The PRMT5 inhibitor arginine methyltransferase inhibitor 1 (AMI‐1) caused cell‐cycle arrest in lung adenocarcinoma cells, which was more pronounced when combined with cisplatin.29 Here, PRMT5 is linked to lung adenocarcinoma.